🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Christian T. Ruff

Brigham and Women's Hospital

ORCID: 0000-0002-4712-3206

Also affiliated with Harvard University, Thrombolysis in Myocardial Infarction Study Group

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 4%percentile
0.826Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Efficacy and Safety of Non–Vitamin-K Antagonist Oral Anticoagulants Versus Warfarin Across the Spectrum of Body Mass Index and Body Weight: An Individual Patient Data Meta-Analysis of 4 Randomized Clinical Trials of Patients With Atrial Fibrillation

Circulation(2024)10.1161/circulationaha.123.066279
Top 24%
0.826DataRank
Top 24%27 citations

Eugene Braunwald, Jan Steffel, Giuseppe Boriani, Michael G. Palazzolo, Elliott M. Antman +12 more

Papers

Driven by 18 papers — median percentile 76. Top paper: “Discovery and systematic characterization of risk variants and genes for coronary artery disease in over a million participants”.

Discovery and systematic characterization of risk variants and genes for coronary artery disease in over a million participants

Nature Genetics(2022)10.1038/s41588-022-01233-6
N/A
7.7DataRank · unranked
721 citations

Tao Jiang, Anuj Goel, Stavroula Kanoni, Brooke N. Wolford, Deepak Atri +92 more

Anticoagulation and Antiplatelet Therapy for Prevention of Venous and Arterial Thrombotic Events in Critically Ill Patients With COVID-19: COVID-PACT

Circulation(2022)10.1161/circulationaha.122.061533
N/A
2.8DataRank · unranked
82 citations

David D. Berg, Mathew S. Lopes, Jean M. Connors, Ijlal Babar, Christopher F. Barnett +94 more

Efficacy and Safety of Non–Vitamin-K Antagonist Oral Anticoagulants Versus Warfarin Across the Spectrum of Body Mass Index and Body Weight: An Individual Patient Data Meta-Analysis of 4 Randomized Clinical Trials of Patients With Atrial Fibrillation

Circulation(2024)10.1161/circulationaha.123.066279
Top 24%
0.826DataRank
Top 24%27 citations

Eugene Braunwald, Jan Steffel, Giuseppe Boriani, Michael G. Palazzolo, Elliott M. Antman +12 more

Dapagliflozin in Patients Hospitalized for Heart Failure: Primary Results of the DAPA ACT HF-TIMI 68 Randomized Clinical Trial and Meta-Analysis of Sodium-Glucose Cotransporter-2 Inhibitors in Patients Hospitalized for Heart Failure

Circulation(2025)10.1161/circulationaha.125.076575
N/A
0.794DataRank · unranked
37 citations

Siddharth M. Patel, Paul M. Haller, Abby L. Cange, Michael G. Palazzolo, Andrea Bellavia +23 more

Type 2 diabetes genetic risk and incident diabetes across diabetes risk enhancers

Diabetes Obesity and Metabolism(2024)10.1111/dom.16123
N/A
0.170DataRank · unranked
2 citations

Frederick Kamanu, Stephen D. Wiviott, Robert P. Giugliano, Miriam S. Udler, Jose C. Florez +5 more

Edoxaban versus warfarin in patients with atrial fibrillation in relation to the risk of stroke: A secondary analysis of the ENGAGE AF-TIMI 48 study

American Heart Journal(2021)10.1016/j.ahj.2021.01.013
N/A
0DataRank · unranked
10 citations

Christian T. Ruff, Sabina A. Murphy, Rose A. Hamershock, Jim T. Vehmeijer, Anton J.M. Oude Ophuis +6 more

Discovery and systematic characterization of risk variants and genes for coronary artery disease in over a million participants

medRxiv(2021)10.1101/2021.05.24.21257377
N/A
0DataRank · unranked
69 citations

Tao Jiang, Anuj Goel, Stavroula Kanoni, Brooke N. Wolford, Elle M. Weeks +87 more

A polygenic risk score predicts atrial fibrillation in cardiovascular disease

European Heart Journal(2022)10.1093/eurheartj/ehac460
N/A
0DataRank · unranked
82 citations

Amanda C. Garfinkel, Frederick Kamanu, Giorgio Melloni, Carolina Roselli, Petr Jarolı́m +15 more

Endophenotype effect sizes support variant pathogenicity in monogenic disease susceptibility genes

Nature Communications(2022)10.1038/s41467-022-32009-5
N/A
0DataRank · unranked
10 citations

Valerie N. Morrill, Seung Hoan Choi, Sean J. Jurgens, Giorgio Melloni, Nicholas Marston +39 more

Risk and benefits of baseline antiplatelet therapy in 58,598 patients with atrial fibrillation randomized to NOACs vs warfarin

European Heart Journal(2023)10.1093/eurheartj/ehad655.2849
N/A
0DataRank · unranked
1 citations

Michael G. Palazzolo, Elliott M. Antman, Eugene Braunwald, Anthony Carnicelli, Stuart J. Connolly +6 more

Clonal hematopoiesis, cardiovascular events and treatment benefit in 63,700 individuals from five TIMI randomized trials

Nature Medicine(2024)10.1038/s41591-024-03188-z
N/A
0DataRank · unranked
42 citations

James P. Pirruccello, Giorgio Melloni, Frederick Kamanu, Marc P. Bonaca, Robert P. Giugliano +12 more

Per-Particle Cardiovascular Risk of Lipoprotein(a) vs Non-Lp(a) Apolipoprotein B-Containing Lipoproteins

Journal of the American College of Cardiology(2024)10.1016/j.jacc.2023.09.836
N/A
0DataRank · unranked
35 citations

Giorgio Melloni, Sabina A. Murphy, Jakub Morze, Frederick Kamanu, Patrick T. Ellinor +3 more

Individual Patient Data from the Pivotal Randomized Controlled Trials of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation (COMBINE AF): Design and Rationale

American Heart Journal(2020)10.1016/j.ahj.2020.12.002
N/A
0DataRank · unranked
32 citations

Hwanhee Hong, Robert P. Giugliano, Stuart J. Connolly, John W. Eikelboom, Manesh R. Patel +12 more

A Polygenic Risk Score to Predict Incident Heart Failure Across the Spectrum of Cardiovascular Risk

Journal of the American College of Cardiology(2025)10.1016/j.jacc.2025.06.050
N/A
0DataRank · unranked
5 citations

Giorgio Melloni, David D. Berg, Frederick Kamanu, Yi-Pin Lai, Elliott M. Antman +17 more

Rationale, considerations, and goals for atrial fibrillation centers of excellence: A Heart Rhythm Society perspective

Heart Rhythm(2020)10.1016/j.hrthm.2020.04.033
N/A
0DataRank · unranked
62 citations

James Allred, T. Jared Bunch, Thomas F. Deering, Luigi Di Biase, Ayman A. Hussein +19 more

Serial assessment of biomarkers and the risk of stroke or systemic embolism and bleeding in patients with atrial fibrillation in the ENGAGE AF-TIMI 48 trial

European Heart Journal(2021)10.1093/eurheartj/ehab141
N/A
0DataRank · unranked
41 citations

Robert P. Giugliano, David D. Berg, Christian T. Ruff, Petr Jarolı́m, Minao Tang +7 more

Evaluating the effects of socioeconomic status on stroke and bleeding risk scores and clinical events in patients on oral anticoagulant for new onset atrial fibrillation

PLoS ONE(2021)10.1371/journal.pone.0248134
N/A
0DataRank · unranked
14 citations

John Weissert, Arshad Jahangir, Christian T. Ruff, Kourosh Ravvaz

Genetic Risk Score to Identify Risk of Venous Thromboembolism in Patients With Cardiometabolic Disease

Circulation Genomic and Precision Medicine(2021)10.1161/circgen.120.003006
N/A
0DataRank · unranked
14 citations

Giorgio Melloni, Yared Gurmu, Marc P. Bonaca, Frederick Kamanu, Carolina Roselli +17 more